ARWR
Arrowhead Pharmaceuticals, Inc. (ARWR) Jumps 7.3% to $61.87
Arrowhead Pharmaceuticals surged 7.3% to $61.87 on Tuesday as a broad rally lifted biotechnology stocks across the sector. The $8.7…
Arrowhead Pharmaceuticals, Inc (ARWR) Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) FY 2026 Other Release
Arrowhead Pharmaceuticals, Inc (ARWR) Sec Form 8K
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Sec Form 8K
Arrowhead Pharmaceuticals, Inc (ARWR) Q1 2026 Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Q1 2026 Earnings Call dated Feb. 05, 2026 Corporate Participants: Vincent Anzalone — Head of…
Arrowhead Pharmaceuticals, Inc (ARWR) Leerink 2026 Global Healthcare Conference
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) FY 2026 Corporate Conference
Arrowhead Pharmaceuticals, Inc (ARWR) TD Cowen 46th Annual Health Care Conference
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) FY 2026 Corporate Conference
Arrowhead Pharmaceuticals, Inc (ARWR) Q1 2026 Earnings Call
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Q1 2026 Earnings Conference
Arrowhead Pharmaceuticals, Inc (ARWR) Sec Form 10Q
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Sec Form 10Q
Arrowhead Pharmaceuticals, Inc (ARWR) Sec Form 8K
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Sec Form 8K
Arrowhead Pharmaceuticals, Inc (ARWR) Q2 2022 Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Q2 2022 Earnings Call dated May. 10, 2022 Corporate Participants: Vincent Anzalone, CFA — Vice…